Superko H R, Hecht H S
Berkeley HeartLab, University of California, Berkeley, California 94010, USA.
Am J Cardiol. 2001 Aug 1;88(3):260-4. doi: 10.1016/s0002-9149(01)01637-x.
This investigation determined the prevalence of low-density lipoprotein (LDL) subclass distribution abnormalities, elevated lipoprotein(a) (Lp(a)), and elevated total plasma homocysteine in asymptomatic subjects with subclinical coronary artery disease determined by electron beam tomography (EBT). Fifty-five percent of subjects were classified as higher risk patients and 45% as lower risk patients, employing the National Cholesterol Education Program (NCEP) lipid criteria. EBT was performed in 296 consecutive asymptomatic subjects, and blood was analyzed for total, LDL, and high-density lipoprotein (HDL) cholesterol, triglycerides, LDL subclass distribution by S(3) gradient gel electrophoresis, Lp(a), and total homocysteine. Disorders of LDL subclass distribution were the most common disorder with 60.6% of the population expressing a distribution in the small regions IIIa + IIIb of >20%; and this was more common in the NCEP higher risk group (LDL cholesterol > or =130 and/or HDL cholesterol <35 mg/dl) (p <0.0004). A Lp(a) value >25 mg/dl was found significantly more often in the NCEP higher (36.9%) compared with lower (14.3%) risk group (p <0.001). None of the laboratory measurements correlated with the calcium score or calcium score percentile rank, with the exception of a weak correlation of mean LDL peak particle diameter and calcium percentile (r = 0.14, p = 0.02). Determination of metabolic disorders in addition to LDL cholesterol and HDL cholesterol increased the diagnostic yield from 55.1%, based on NCEP lipid criteria, to 84.1% with the addition of LDL subclass distribution, Lp(a), and total homocysteine. We conclude that: (1) disorders of LDL subclass distribution and elevated Lp(a) occur frequently in NCEP higher risk patients with subclinical coronary artery disease and are the only identifiable disorders in lower NCEP risk patients; and (2) electron beam tomographic evaluation and determination of LDL subclass distribution and Lp(a) should be considered for incorporation into primary prevention guidelines.
本研究通过电子束断层扫描(EBT)确定了无症状亚临床冠状动脉疾病患者中低密度脂蛋白(LDL)亚类分布异常、脂蛋白(a)[Lp(a)]升高以及血浆总同型半胱氨酸升高的患病率。采用美国国家胆固醇教育计划(NCEP)的血脂标准,55%的受试者被归类为高危患者,45%为低危患者。对296名连续的无症状受试者进行了EBT检查,并对血液进行了总胆固醇、LDL胆固醇、高密度脂蛋白(HDL)胆固醇、甘油三酯、通过S(3)梯度凝胶电泳分析的LDL亚类分布、Lp(a)和总同型半胱氨酸检测。LDL亚类分布紊乱是最常见的紊乱情况,60.6%的人群在小区域IIIa + IIIb中的分布>20%;在NCEP高危组(LDL胆固醇>或=130且/或HDL胆固醇<35mg/dl)中更为常见(p<0.0004)。与低危组(14.3%)相比,NCEP高危组(36.9%)中Lp(a)值>25mg/dl的情况明显更常见(p<0.001)。除了平均LDL峰值颗粒直径与钙百分位数存在弱相关性(r = 0.14,p = 0.02)外,没有任何实验室检测结果与钙评分或钙评分百分位排名相关。除了LDL胆固醇和HDL胆固醇外,对代谢紊乱进行检测,将基于NCEP血脂标准的诊断率从55.1%提高到了加入LDL亚类分布、Lp(a)和总同型半胱氨酸后的84.1%。我们得出以下结论:(1)LDL亚类分布紊乱和Lp(a)升高在NCEP高危亚临床冠状动脉疾病患者中频繁出现,并且是NCEP低危患者中唯一可识别的紊乱情况;(2)应考虑将电子束断层扫描评估以及LDL亚类分布和Lp(a)的检测纳入一级预防指南。